Java application program to calculate property tax.

Prompt users for the number of

properties.

Prompt users for property tax.

Prompt users to input the value for each property

Calculate  the TOTAL amount of all property tax combined – Cant get it  to  multiply each property by property tax then  combine all.

User must press “E” to terminate the program.

Assignment: Transnational Crime



ORDER NOW FOR AN ORIGINAL PLAGIARISM-FREE PAPER: Assignment: Transnational Crime

Assignment: Transnational Crime

Assignment: Transnational Crime

Explore a culture that has been linked to criminal behavior. At one time or another all cultures have had some link to criminal behavior, whether that’s organized crime, drug trafficking, terrorism, or civil disobedience. In a 12–15 PowerPoint slide presentation (excluding title and reference slides) complete the following:

Identify one culture or ethnicity that has ties to transnational crime, and describe its links to criminal behavior.

Evaluate its role in transnational crimes.

Analyze and explain how this culture or ethnicity has had an impact on systems of justice.

Be sure to discuss the role that socialization and religion play in shaping the beliefs of this culture. Provide examples determining why these beliefs are formed, and how culture and religion shaped these beliefs. Be sure to use speaker notes as well.

You will need to use a minimum of 3 academic sources. Use Google Scholar, JSTOR, textbooks, and/or .gov websites to keep the true academic sources in your papers. TURNITIN MUST BE UNDER 20% Make sure to write a few sentences discussing how you evaluated the credibility of your sources.

Explore a culture that has been linked to criminal behavior. At one time or another all cultures have had some link to criminal behavior, whether that’s organized crime, drug trafficking, terrorism, or civil disobedience. In a 12–15 PowerPoint slide presentation (excluding title and reference slides) complete the following:

Identify one culture or ethnicity that has ties to transnational crime, and describe its links to criminal behavior.

Evaluate its role in transnational crimes.

Analyze and explain how this culture or ethnicity has had an impact on systems of justice.

Be sure to discuss the role that socialization and religion play in shaping the beliefs of this culture. Provide examples determining why these beliefs are formed, and how culture and religion shaped these beliefs. Be sure to use speaker notes as well.

You will need to use a minimum of 3 academic sources. Use Google Scholar, JSTOR, textbooks, and/or .gov websites to keep the true academic sources in your papers. TURNITIN MUST BE UNDER 20% Make sure to write a few sentences discussing how you evaluated the credibility of your sources.

Get a



10 %


discount on an order above



$ 50

Use the following coupon code :


NursingPapers

: Identify at least 3 healthcare-related tools (apps, devices, etc.) and/or other resources available today for consumers (patients/caregivers) of healthcare services and describe how they can increase patient engagement.

: Identify at least 3 healthcare-related tools (apps, devices, etc.) and/or other resources available today for consumers (patients/caregivers) of healthcare services and describe how they can increase patient engagement.

Social media is playing a key role in the healthcare industry today. Various social media platforms include Facebook, LinkedIn, Twitter, blogs, etc. In this course, you will create your own blog to discuss some of the important topics and policies related to healthcare information systems and corresponding technologies.

Begin by creating your own blog, using a free editor such as Wix.com.

For the week #2 course project assignment, create 2 new blog posts addressing the following questions:

1. Identify at least 3 healthcare-related tools (apps, devices, etc.) and/or other resources available today for consumers (patients/caregivers) of healthcare services and describe how they can increase patient engagement.

2. Research the local or state HIE in your area. Who are the key players involved? What services do they provide? What accomplishments have they been able to demonstrate thus far, if any? What challenges have they faced?

Ethical Issues of Sexually Transmitted Infections (STIs)


Identify a specific situation, from your own experience in practice, where an ethical issue arose. With regard to confidentiality, outline the situation and explore the issues involved. Using appropriate ethical theory/principles, analyse the situation and the action taken to resolve the problem.

In this essay we shall consider the case of Mrs.P., a 39 yr. old married mother of three who attended at a gynaecology clinic with menorrhagia. She was investigated and was found to have, amongst other things, a chlamydial infection.

She was horrified. On questioning, she was initially incensed and stated that the path lab must have made a mistake and that such a thing “simply was not possible”, she denied any knowledge of how such an infection could have been contracted and asked the staff if it meant that her husband had been unfaithful. It was about half an hour after the news had been broken and the rest of her problems had been dealt with, that the staff moved onto the delicate matter of contact tracing.

It was only then that Mrs.P. eventually confided that she had had a number of clandestine relationships without her husband knowing. One of these relationships was with her husband’s best friend from his work (Mr. H). She was adamant that neither he nor her husband should be told, as she could not face the consequences from the inevitable fall out. The clinic staff were also told that Mr and Mrs H were desperate to have a baby and that Mrs H was about to consider going for referral for infertility investigations.

There are many ethical issues in this small clinical encounter and they represent, as a generalisation, issues that are typical of many ethical difficulties that present to healthcare professionals in the UK on a daily basis.

The subject of medical ethics has evolved over a huge length of time and is, in part, dependent on the circumstances and environment in which it is applied. (Veitch RM 2002). In this essay we shall consider these ethical difficulties as they pertain to Mrs.P., but before we consider them in detail, let us consider the overriding ethical principles that should guide the actions of those concerned.

We can start with a historical note. If we consider Hippocrates’ often quoted dictum “first do no harm”, (Carrick P 2000), we will see that it underpins the first guiding principle of ethics, that of Non-Maleficence. This means “no malice”. It places an implied burden on any healthcare professional to not only avoid doing harm to a patient, but also to take active steps to make sure that harm does not occur through accident or negligence.

The Principle of Beneficence takes the argument further with an expectation of doing good or “goodness” as a quality. As we have suggested earlier, this quality is variable and is judged in the circumstances in which it occurs. This is particularly relevant in questions relating to consent which again, is central to the case of Mrs.P. (McMillian J 2005)

The third principle of ethics that is relevant to our considerations here is the Principle of Dentology which places an expectation on the healthcare professional to act in a way that means that decisions are made in the patient’s best interests and are not in any way influenced by other considerations such as cost or expediency. (Tännsjö T 2005)

There is then the consideration of autonomy. In the case of Mrs.P. this effectively means that she is allowed to make her own decisions based on her own free will and is not forced (either figuratively or expressly) into a situation where she feels pressurised into decisions against her will. She should be allowed to consider what is right for her, in her current circumstances, without feeling that she is being coerced by any form of outside influence.(Mill JS 1982)

It clearly follows from this statement that Mrs.P. can only make such a decision if she is in full possession of all of the relevant facts relating to her circumstance and this then opens up another field of debate, one relating to the role of the healthcare professional as an information resource. It is incumbent on the healthcare professionals advising Mrs.P. that they would ensure that she has available to her (in a form that she can understand) all of the information necessary to allow her to make up her own mind on the issues presenting themselves. (Sugarman J & Sulmasy 2001)


Chlamydia

In order to appreciate the full implication of the decisions and dilemmas facing Mrs.P., we should firstly consider the issues of the pathophysiology of chlamydia. It is commonly accepted that a large proportion of what was previously called NSU or even undiagnosed genital discharge, was probably infection due to chlamydia. It currently ranks as being responsible for numerically the greatest number of sexually transmitted diseases in the UK in the present day. (Duncan 1998)

The actual incidence of detected chlamydia varies between different sociological groups and is dependent on the study. Adams (et al 2004) produced a huge meta analysis of UK data and suggested that the incidence varies from 8.1% of the under 20 age group to 1.4% of the over 30 group

Equally it can be seen that other studies, (Piementa et al 2003), put the incidence in the under 20 group as high as 17% and in antenatal clinics (whole population) at 12%. There is no merit in debating the statistical validity of these figures, they are presented to underline the point that Mrs.P.’s dilemma is not a rare one.

If we take an overview of the whole chlamydia issue we can cite the opinion of National Institute for Clinical Excellence (NICE) who quote that, in their rationale for a national screening programme, chlamydia:

Is the commonest Sexually Transmitted Infection (STI) in England

Is an important reproductive health problem ~ 10-30% of infected women develop pelvic inflammatory disease (PID).

In a significant proportion of cases, particularly amongst women, are asymptomatic and so, are liable to remain undetected, putting women at risk of developing PID.

Screening may reduce incidence of PID and ectopic pregnancy.

These points are presented as underlining the argument that we will make later in this essay, that a diagnosis of chlamydial infection – although commonly asymptomatic (especially in men), is actually far from trivial and therefore should not be taken lightly or dismissively.


Discussion

With specific reference to Mrs.P. we should note that there are two important factors that should influence our discussions here. One is the relevance to Mr H. and his wife and the possible implications to their apparent infertility, and the second is effectively the contact tracing arguments and the degree that the healthcare professional should be involved in making Mr H. aware of the possibility that he may have the chlamydial infection.

Let us begin by considering an excellent and informative paper by Cassell (et al 2003) on the issue of partner notification. The authors are of the opinion that, due to factors such as the explosion in the numbers and the evolution of the Health Service, that the thorny issue of partner notification, which had previously largely fallen into the domain of the GUM clinic nurse, had now evolved to involve General Practice staff, obstetric and gynaecology clinic staff as well as many others. The corollary of this is that this role has lost some of its efficiency in skill resources and time. (D of H 2002).

The paper itself is very informative, but if we restrict ourselves to a consideration of those aspects which are directly referable to our considerations here. With regard to the issue of patient confidentiality and contact informing, only 40% of the healthcare professionals questioned thought that partner notification was actually their role. The remaining 60% took the view that it was their role to inform the patient of what they saw was their responsibility to inform their own partners.

The reason that we make this point is that over at least the last two decades, there has been a noticeable and welcome shift to the general acceptance of evidence based medicine (Berwick D 2005). The point is therefore made that if this evidence is accepted, then we could assume that the majority of healthcare professionals believe that their responsibility to inform the patient’s partner ends with their discussion of the matter with the patient. This is relevant if one considers the Bolam principal which has been the foundation of the legal view of matters of medical negligence. The Bolam test, when applied to this type of situation states that:

A healthcare professional is not negligent if he or she acts in accordance with practice accepted at the time by a responsible body of medical opinion.

In other words, if one acts in accordance with the rules that govern normal medical and nursing practice. In these circumstances it would appear that the majority medical opinion is that one’s burden of responsibility is limited to telling the patient that they should tell their own sexual partners of their infection.

To a degree, this view is at odds with other ethical considerations, as one might consider that one has an obligation both to Mrs.P.’s husband who may clearly be at risk from chlamydial infection and complications, and also Mr. H and his partner, who may even already be suffering from complications, as they are considering being investigated for infertility. In these eventualities one has to consider if one is breaching any or all of the three principles that we have already outlined above. On the face of it, it would appear that all three principles are being compromised by this course of action.

Non-maleficence – because of the implied failure to take active steps to protect Mrs.P.’s partners from potential harm.

Beneficence because of Mrs.P.’s failure to agree to consent to anyone telling her partners on her behalf

Dentology becaues it could be argued that a suggestion that the healthcare professional should tell Mrs.P.‘s partners means that decisions are being made on the grounds of expediency rather than necessarily in Mrs.P.’s best interest (as Mrs.P. sees it).

The only principle that appears to be upheld with this particular view is that of Mrs.P.’s autonomy.

We can explore this issue further. Mrs.P.’s refusal to inform her partners may be, at first sight, understandable. But there are other issues that we must consider before passing moral judgement on her. If we consider a paper by Duncan (Duncan B et al 1998). This provides a very informative insight into the issues that confront women in this situation and she cites a common finding of equating a perception of “being dirty” or promiscuity with a positive test. There is also the issue of both men and women feeling embarrassed to get tested, although, with the advent of General Practice based testing and testing away from the stigma of the GUM clinics, this may well be less of a problem.

It also follows from this study finding that there is a major Public Health Education paradox here. If it is true that the majority of healthcare professionals actually believe that it is the responsibility of the patient to tell their partner and this fact is augmented by the discovery that another study found that nearly 20% of respondents actually chose to treat chlamydia with a dose of antibiotic which is less than the currently recommended therapeutic level recommended by the Central Audit Group for Genitourinary Medicine, (Stokes et al 1997), it is perhaps not a surprising observation that the level of chlamydial infection is apparently as high in the community as it is.

It follows from this that the authors of another study in a similar area can make the comment:

If testing in primary care continues to increase without adequate support for partner notification, much of the resource used in testing women will be wasted. (Griffiths et al 2002)

To provide a balanced view on the subject we should observe that the converse of our argument so far is put by other workers in the field (EHC 1999), who argue for the enhancement of the contact tracing facilitators and facilities in order to “properly maximise a reduction in the risk of both personal re-infection and the level of infection in the community”

The central importance of this argument is exemplified in an excellent paper by Patel (HC et al 2004). This looked at the reliability of contact tracing mechanisms. The paper itself is both long and involved. It followed up over 250 patients over a five year period. in short, the authors reported that if the infected patient had a regular partner, they were likely to turn up for treatment in about 53% of cases, whereas if there was an extramarital partner only about 13% would receive treatment. The implication is clearly (although it is obviously admitted that there are significant confounding factors), that an infected patient is far more likely to tell their marriage partner than an extramarital sexual partner.


Conclusions and suggestions for practice.

In order to help with such considerations we note that the main professional bodies issue their own comprehensive guidelines. They are issued jointly by both the BMA and RCN for all healthcare professionals(Dimond. B. 1999). The documents themselves are unsurprisingly enormous, and offer outline guidance on virtually every major issue and they follow the principles that we have already set out. They equally make the point that not every eventuality can either be predicted or catered for, and in these circumstances the healthcare professional is left to make their own judgement based on their interpretation of the underlying principles and circumstances.

In our interpretation of these principles, it would appear that the overriding consideration in the case of Mrs.P. is that of autonomy. There may well be a substantial evidence base that we could point to which would suggest that Mrs.P.’s refusal to tell either her husband or sexual partner could have serious and possibly long lasting adverse effects on their health. But in the last analysis, Mrs.P. has the right of consent to her personal details being divulged – either explicitly or by inference and implication – to any other person. If that consent or permission is withheld then the healthcare professional would be expected to respect that right, even if they had personal difficulty with it themselves.

There is an implicit obligation on healthcare professional not only to enhance the patient’s autonomy but also to take as many steps as possible to ensure that any decision reached by the patient is truly autonomous. The professional guidelines suggest that one of the best ways of doing this is primarily by the giving of as much information as possible, particularly that information which is judged to be of importance in assisting them in making their decisions (Williamson C 2005)

This view seems to be echoed by the legal profession who have pointed to the fact ( in case law) that each adult has a right to their own autonomy. (Donaldson L 1993). The guiding pronouncement in this type of issue is that a legally competent adult has the right to agree or to disagree with any form of treatment or opinion offered by a healthcare professional and does not have to justify the reason for their action to anyone else.

It is clearly incumbent on the healthcare professional to try to provide the Public Health information to help the patient make an informed and considered decision. It may even be considered acceptable to suggest or persuade the patient to “do the honourable thing”, but this clearly must not be interpreted as placing undue pressure on the patient otherwise all of the underlying ethical principles discussed so far will be completely undermined (Hendrick, J. 2000).

We should also note that the same professional guidelines cited above also make the suggestion that the nature of the conversation and the topics discussed should be clearly recorded in the patient’s notes and if a decision is made to allow healthcare professionals to contact the other potential partners, then a consent form recording the decision should ideally be signed by the patient. In many instances we acknowledge that it is common practice to advise and take whatever action is perceived to be in the best interests of the patient, but in terms of our ever more litigious society, it appears to be good advice to get written consent for virtually every action however seemingly minor. (Yura H et al 1998),

If we had to sum up the thrust of this essay in a sentence it would be that there is no excuse – either ethically, or for that matter in law – for making unfounded assumptions about what the patient wants or will permit. (Gillon. R. 1997).


References

Adams EJ , A Charlett, W J Edmunds, and G Hughes 2004 Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies Sex. Transm. Inf., October 1, 2004; 80(5): 354 – 362.

Berwick D 2005 Broadening the view of evidence-based medicine Qual. Saf. Health Care, Oct 2005; 14: 315 – 316.

Carrick P 2000 Medical Ethics in the Ancient World Georgetown University press 2000 ISBN: 0878408495

Cassell JA , M G Brook, R Slack, N James, A Hayward, and A M Johnson 2003 Partner notification in primary care Sex. Transm. Inf., June 1, 2003; 79(3): 264 – 265.

Dimond. B. 2001 Legal Aspects of Consent Salisbury.: Quay Books 2001

D of H 2002 Department of Health. The national strategy for sexual health and HIV: implementation action plan. London: DoH, 2002.

Donaldson L 1993 in Re T (Adult: Refusal of Treatment) [1993) Fam 95 5

Duncan B, Hart G. 1998 Screening for Chlamydia trachomatis: a qualitative study of women’s views. Prevenir 1998; (suppl 24): 229.

EHC 1999 Effective Health Care. Getting evidence into practice. York: University of York, 1999.

Gillon. R. 1997. Autonomy London: Blackwell 1997

Griffiths C, Cuddigan A. 2002 Clinical management of chlamydia in general practice: A survey of reported practice.

J Fam Plann Reprod Health Care 2002;28:149–52.

Hendrick, J. (2000) Law and Ethics in Nursing and Health Care, London. Stanley Thornes 2000

McMillan J 2005 Doing what’s best and best interests BMJ, May 2005; 330: 1069 ;

Mill JS 1982 On Liberty, 1982, Harmondsworth: Penguin, p 68.

Patel HC, Viswalingham ND, Goh BT 2004

Chlamydial ocular infection: efficacy of partner notification by patient referral. Int. J. STD AIDS 2004 Jul-Aug;5(4):244-7.

Stokes T, Bhaduri S, Schober P, et al. 1997 GPs’ management of genital chlamydia: a survey of reported practice. Fam Pract 1997;14:455–60

Sugarman J & Sulmasy 2001 Methods in Medical Ethics Georgetown Univeristy Press 2001 ISBN: 0878408738

Tännsjö T 2005 Moral dimensions BMJ, Sep 2005; 331: 689 – 691 ;

Veitch RM 2002 Cross-cultural perspectives in medical ethics

Jones & Bartlett 2002 ISBN: 0763713325

Williamson C 2005 Withholding policies from patients restricts their autonomy BMJ, Nov 2005; 331: 1078 – 1080 ;

Yura H, Walsh M. 1998 The nursing process. Assessing, planning, implementing, evaluating. 5th edition. Norwalk, CT: Appleton & Lange, 1998.

#############################################################

20.2.06 PDG Word count 3,184

How do you think guidance and coaching in the advanced practice role is different from the RN role of teaching/coaching? Are there certain elements of this competency that are more important than others?

How do you think guidance and coaching in the advanced practice role is different from the RN role of teaching/coaching? Are there certain elements of this competency that are more important than others?

 

Advanced Nursing Roles

Order Description

Guidance and Coaching Competencies

Guidance and coaching is a core competency of advanced practice nursing. How do you think guidance and coaching in the advanced practice role is different from the RN role of teaching/coaching? Are there certain elements of this competency that are more important than others? How does the teaching and coaching role fit with a wellness versus sickness model of care?

How does the brain work before and after Alzheimer disease ?

How does the brain work before and after Alzheimer disease ?

Project description How the brain work before and after alzheimer disease ?200 The difination of Alzheimer’s ?100words How alzheimer disease start? 100 words The role of environment in alzheimer disease?200 Causes of alzheimer diseases ?200words Symptoms of Alzheimer’s disease ?100words

Reflect (suggested length of 1 page) on your professional definition of quality and safety developed in Professional Roles and Values.

Reflect (suggested length of 1 page) on your professional definition of quality and safety developed in Professional Roles and Values.

Paper , Order, or Assignment Requirements

Introduction:

A professional portfolio will showcase your knowledge and skills to prospective employers and will increase your marketability as a baccalaureate-prepared nurse. This portfolio will help you, as a nurse, home in on the concepts, strengths, and critical-thinking abilities that define professional nursing practice. Throughout your time at WGU, you have developed skills and knowledge that distinguish your practice as that of a baccalaureate-prepared nurse. Items that display your skills and knowledge will be showcased in this professional portfolio. You should organize your portfolio around the four areas of professional nursing practice: quality and safety, advanced evidence-based practice, applied leadership, and community health. This portfolio will expand on the portfolio you already created in your Professional Roles and Values course.

When you are ready to submit your portfolio for evaluation, please follow the “How to Submit Your Portfolio for Evaluation” document below.

Requirements:

Your submission must be your original work. No more than a combined total of 30% of the submission and no more than a 10% match to any one individual source can be directly quoted or closely paraphrased from sources, even if cited correctly. Use the Turnitin Originality Report available in Taskstream as a guide for this measure of originality.

You must use the rubric to direct the creation of your submission because it provides detailed criteria that will be used to evaluate your work. Each requirement below may be evaluated by more than one rubric aspect. The rubric aspect titles may contain hyperlinks to relevant portions of the course.

A. Complete the following, using the Web Folio Builder (in Taskstream) that you used to create your portfolio in the Professional Roles and Values course:

Note: The Web Folio Builder can be found on the “Folios & Web Pages” link located in the static bar below the WGU logo.

1. Create a professional mission statement (suggested length of 1 paragraph) that includes the following:
? representation of your career goals, your aspirations, and how you want to move forward with your career
? overview of where you would like to focus your time and energies within the profession
a. Reflect on how your professional mission statement will help guide you throughout your nursing career.
2. Complete a professional summary (suggested length of 3–4 pages) that includes the following:
a. Explain how the specific artifacts or completed work or both in your portfolio represent you as a learner and a healthcare professional.
b. Discuss how the specific artifacts in your portfolio represent your professional strengths.
c. Discuss challenges you encountered during the progression of your program.
i. Explain how you overcame these challenges.
d. Explain how your coursework helped you meet each of the nine nursing program outcomes.

Note: Refer to the attachment below titled “Nursing Conceptual Model.”

e. Analyze how you fulfilled the following roles during your program:
• scientist
• detective
• manager of the healing environment
f. Discuss how you have grown professionally since the beginning of your program.

B. Complete the following within the section “Quality and Safety”:
1. Reflect (suggested length of 1 page) on your professional definition of quality and safety developed in Professional Roles and Values, including any necessary changes to your definition.
a. Discuss how the program assisted you in developing your professional definition.
b. Identify the artifacts in your portfolio that support your definition.

Note: The artifacts should be attached within the portfolio.

i. Explain how these artifacts support your definition from part B1.
2. Discuss the importance of the Institute for Healthcare Improvement (IHI) certificate for your future role as a professional nurse.

C. Complete the following within the section “Evidence-Based Practice”:
1. Reflect (suggested length of 1 page) on your professional definition of evidence-based practice developed in Professional Roles and Values, including any necessary changes to your definition.
a. Discuss how the program assisted you in developing your professional definition.
b. Identify the artifacts in your portfolio that support your definition.

Note: The artifacts should be attached within the portfolio.

i. Explain how these artifacts support your definition from part C1.
2. Reflect (suggested length of 1 page) on your understanding of evidence-based practice and applied nursing research by doing the following:
a. Discuss how you are able to evaluate current primary research and apply the concepts to your nursing practice, considering the following:
• relevancy and believability of data
• differences between quality improvement and research (places and uses of each)
• differences between primary and secondary research and resources and the implications of each in clinical practice
b. Explain how your experience in the program helped you achieve excellence in evidence-based practice.

D. Complete the following within the section “Applied Leadership”:
1. Reflect (suggested length of 1 page) on your professional definition of applied leadership you developed in Professional Roles and Values, including any necessary changes to your definition.
a. Discuss how the program assisted you in developing your professional definition.
b. Identify the artifacts in your portfolio that support your definition.

Note: The artifacts should be attached within the portfolio.

i. Explain how these artifacts support the definition from part D1.
2. Summarize (suggested length of 1 paragraph to 1 page) your Learning Leadership Experience task by doing the following:
a. Discuss the importance of professional collaboration for effective nursing leadership.

E. Complete the following within the section “Community Health”:
1. Reflect (suggested length of 1 page) on your professional definition of community and health you developed in Professional Roles and Values, including any necessary changes to your definition.
a. Discuss how the program assisted you in developing your professional definition.
b. Identify the artifacts in your portfolio that support your definition.

Note: The artifacts should be attached within the portfolio.

i. Explain how these artifacts support the definition from part E1.
2. Summarize (suggested length of 1 page) your Community Health task by doing the following:
a. Discuss what you learned during your Community Health Nursing task.
b. Discuss what you learned led to your community diagnosis.
c. Discuss how your initial focus and diagnosis evolved after working with your population.
3. Discuss the importance of the American Museum of Natural History (AMNH) certificate for your future role as a professional nurse.

F. Provide an appendix to your portfolio by doing the following:
1. Include all the documents, prior assignments, and additional items that are examples of your best work to support your mastery of all sections given in parts B, C, D, and E.
2. Include the following materials:
• the attached “Nursing Conceptual Model”
• a link to the current IHI Course Catalog
3. Provide an updated professional résumé.

Note: If you have a LinkedIn account, you can take a screenshot and include a copy with the rest of your documents.

4. Provide professional references, using one of the following:
• a professional reference questionnaire
• a full letter of recommendation
• a list of four professional references
5. Include a copy of your IHI certificate of completion.
6. Include a copy of your AMNH certificate of completion.

Lack of Adherence to Medications

Lack of Adherence to Medications

Most chronic diseases require long term use of prescribed medications. Medication non-adherence is a long-standing major concern when assisting patients with the management of a chronic disease.

Write a six (6) to ten (10) page paper (excludes cover and reference page) that addresses medication nonadherence. The paper consists of two (2) parts and must be submitted by the close of week six. Each part must be a minimum of three (3) pages in length.

A minimum of three (3) current professional references must be provided. Current references include professional publications or valid and current websites dated within five (5) years. Additionally, a textbook that is no more than one (1) edition old may be used.

Select a disorder or disease included in the content of this course to use as a basis for this paper and address the following:

Part 1:

Define medication nonadherence.
Identify the health disorder or disease selected as a basis for this paper. Discuss the extent of medication nonadherence for the chosen health disorder or disease.
Identify the medication regimen required to manage the disease. Include the drug categories, one (1) example of each medication in the category, and the action of each medication.
Part 2:

Identify three (3) consequences of nonadherence to medication regimen in the population selected.
Identify three (3) factors that are associated with medication nonadherence and discuss how they contribute to this long standing problem.
Describe (3) nursing strategies that can be applied to promote medication adherence.

Study Completed On Congestive Heart Failure Nursing Essay

Congestive heart failure due to left ventricular systolic dysfunction (LVSD) is an increasingly prevalent and progressive condition that leads to disability and death, placing a significant burden on patients, carers and health care providers. Debilitating clinical symptoms such as breathlessness, fatigue, and fluid retention usually develop over time and are associated with a reduction in functional capacity (National Collaborative Centre for Chronic Conditions, 2006). Coronary heart disease is the most common cause of heart failure; however there are other nonischaemic causes such as hypertension, valvular disease, thyroid disease, excess alcohol or myocarditis (Scottish Intercollegiate Guidelines Network (SIGN) 2007). The paper briefly discusses about “Congestive Heart Failure” and analyses it medication and treatment.

Congestive heart failure is the only cardiovascular disease increasing in incidence. A combination of improved cardiological treatments and risk factor trends are thought to be responsible for this (Bryant et al, 2007). It is estimated that 66 000 new cases of heart failure are diagnosed in the UK every year and that 912 000 of the population aged 45 years and over have definite/probable heart failure (Bryant et al, 2007). Life expectancy is increasing and the incidence of heart failure in the 75-84 years age group is 7%, and 15% in those aged 85 years and above (British Heart Foundation, 2007).

Discussion

Heart Failure Progression and Mortality

Th e British Heart Foundation (BHF) estimates that 4% of deaths each year in the UK are attributable to heart failure (all forms) and that 40% of deaths occur within 1 year of diagnosis (BHF, 2006). Patient symptoms can vary and can oft en be a combination of breathlessness, peripheral oedema and extreme fatigue. The severity of these symptoms is assessed using the New York Heart Association Classification (NYHA), the most widely-used functional capacity grading tool as recommended by SIGN (2007).

Treatment

Major clinical trials involving a combination of ACE inhibitors, beta blockers, angiotensin II receptor blockers, aldosterone receptor blocker and diuretics, titrated at timely intervals until either a target or maximally-tolerated dose is reached, have improved clinical knowledge and management of heart failure. Specific guidelines relating to all of the above and including non-pharmacological measures have been recommended by the National Institute for Health and Clinical Excellence (National Collaborative Centre for Chronic Conditions, 2006) and SIGN (2007). Optimal management of heart failure patients can be difficult to achieve and requires skilful patient assessment and intensive monitoring. Lehne, (2007) found that nurse-led heart failure management programmes proved successful and cost-effective through their ability to co-ordinate and implement evidence-based care. This reduced the financial impact on the health care system, estimated at between 1-4% of the total NHS expenditure (Lehne, 2007). Gaps identified Johnson and Lehman (2006) highlight heart failure as having a worst survival rate than most of the common cancers and Aldred (2009) states that patients have a poorer quality of life than those with most other chronic progressive diseases. The National Council for Palliative Care (2005) also states that patients dying from advanced heart failure still remain disadvantaged compared to their peers suffering from cancer in terms of symptom control management, communication and access to palliative care support networks.

Why Is This?

Health professionals caring for dying patients with heart failure continue to face a number of practical problems. For example, the disease trajectory of congestive heart failure is ill defined; episodes of acute decompensation generally increase in frequency and severity until one such episode proves fatal, and there remains a significant risk of sudden death-50% at all stages of the disease (Scottish Partnership for Palliative Care (SPPC), 2008). In addition there is little robust end-of-life research about: functional status, quality of life, symptom prevalence or severity, and decisions about treatment preference. Studies that do exist demonstrate high rates of unmet needs in the areas of symptom management, communication, decision making, emotional support, co-ordination of care and quality end-of life care (Hancock et al, 2007; Anderson et al, 2006; Pantilat and Steimle, 2007).

Specific knowledge gaps among health professionals include recognizing vulnerable patient groups, advanced communication skills and advanced care planning. Although it is widely recognized that most heart failure nurses work at a specialized level providing structured supportive care from diagnosis onwards, difficulties still arise around discussion and integration of end-of-life care priorities. For many heart failure nurses the opportunity to enroll in advanced communication or palliative care training events to support role development in this area has not been possible (Lehne, 2007). However, supporting these learning needs is now being addressed nationally through the BHF and a number of higher educational institutions.

Palliative Care

Palliative care is defined as an interdisciplinary team approach to optimizing symptom management and enhancing quality of life by considering physical, psychosocial and spiritual needs as well as skilful communication in relation to prognosis, treatment and issues of importance to both patient and carers. Barriers to the integration of palliative care in heart failure care are still very evident today. Th ere is still a reluctance to recognize high-risk patients, the medical model of intervention still mainly focuses on the struggle and maintenance of vital functions rather than the human suffering associated with that maintenance (Copstead, 2010), and gaps in knowledge often lead to poor communication and co-ordination of care that very oft en results in inappropriate hospital admission (Millerick and Blue, 2007). Key policy recommendations Key policy initiatives throughout the UK recommend integrating palliative care into mainstream health care for patients and carers living with life-limiting disease such as heart failure (Scottish Government, 2007; Department of Health, 2008)

Th e Scottish Partnership for Palliative Care (SPPC) published a report in March 2008 entitled ‘Living and Dying with Advanced Heart Failure: A Palliative Care Approach’. The main areas for action from all of these initiatives are reflected in the following recommendations (SPPC, 2008): All patients with advanced heart failure should be provided with both optimum cardiological management (drugs and devices) and supportive/palliative care; Health care teams should adopt a holistic approach to care, ensuring optimum management of physical, social, psychological, emotional and spiritual needs; Sufficient opportunities should be given to patients and carers to discuss any issues important to them at their own pace and the time of their choosing; Collaborative working between different health care teams should be implemented; Arrangements for appropriate end of life care should be put in place; Reciprocal educational and training opportunities should be provided to all health and social care professionals to enhance understanding of cardiological and general palliative care; Further palliative care research should be undertaken to determine best practice guidelines Identification of high-risk patients It is oft en difficult to predict the individual prognosis of heart failure patients, as most patients will at some point during their illness trajectory experience symptoms that may appear resistant to adjustment of cardiological therapy (Copstead, 2010). It is important however to emphasize that optimum cardiological management (both drugs and devices) is of huge significance to heart failure patients as it can have a major effect on their survival and symptom control (SPPC, 2008). Therefore when identifying appropriate patients it is essential to ensure that heart failure medication has been optimized.

Collaborative working

Collaborative working with key professionals continues beyond the discussion, assessment and documentation and is continued with the patient and carer during a joint home visit, normally involving a heart failure and palliative care specialist nurse (Lehne, 2007). During this visit a holistic assessment of the patient’s and carer’s needs is carried out ensuring that physical, social, psychological, emotional and spiritual needs are addressed. Th is collaborative style of working whereby two specialists are working towards the same goals leads to an informal transfer of knowledge and skills. It is important that during this consultation realistic facilitation of care priorities is discussed and implemented to avoid patient and carer disappointment. An example of this would be a patient requiring a hospital admission for acute symptom management, particularly in the absence of robust community diuretic protocols.

Rapid assessment, appropriate treatment and intervention should always be implemented, avoiding inappropriate investigations and lengthy delays as far as possible. Once the patient is stabilized the fast track process should endeavour to respect the wishes of the patient and carer and where appropriate home discharge should always be prioritized over a hospital admission. However, if a hospital admission cannot be avoided the patient should be fast tracked to an appropriate bed area, preferably one that is familiar to the patient and family, and every effort should be made to ensure that the hospital stay is as short as possible.

Mediation Analysis

Studies combining ACE inhibitors and A2RAs have given varied results (Hibbert, 2008). In general, ACE inhibitors should be seen as the first choice, and the A2RAs should be reserved for patients who are intolerant of ACE inhibitors because of cough (Anderson, 2007). Concerns have recently been expressed that this group of drugs may increase the risk of myocardial infarction.

Studies combining ACE inhibitors and A2RAs have given varied results. In general, ACE inhibitors should be seen as the first choice, and the A2RAs should be reserved for patients who are intolerant of ACE inhibitors because of cough (Hibbert, 2008). Concerns have recently been expressed that this group of drugs may increase the risk of myocardial infarction. Clearly no treatment, however successful, will be widely accepted unless it is also safe and easy to use. It is here that there has been concern about ACE inhibitors, largely based on widely publicised reports of severe hypotension and renal dysfunction in early studies with large doses of these drugs in severely ill patients (Hibbert, 2008). This experience has left a residual reluctance, especially among non-cardiologists, to use ACE inhibitors in CHF. Thus, concern about frequent or serious adverse effects in mild to moderate CHF should not be a reason for depriving patients of life-prolonging therapy (Anderson, 2007). The message from the trials is that all patients with CHF due to myocardial systolic dysfunction should be given an ACE inhibitor; there is no reason to suppose that one ACE inhibitor would confer any special benefit over another. To prescribe a diuretic and delay ACE inhibitor therapy is no longer supportable (Anderson, 2007).

Generally ACE inhibition results in a diminished systemic vascular resistance, blood pressure, preload and afterload. (Aldred, 2009) ACE plays a role in the degradation of bradykinin. There is evidence that ACE inhibitors are responsible for the inhibition of this pathway resulting in an increased level of bradykinin, a naturally occurring vasodilator (Weir, 2006). The degree of hypotensive response does not usually correlate with pre-treatment levels of plasma rennin activity.

A reduction in blood pressure because of ACE is not usually accompanied by changes in heart rate, pressor sensitivity to exogenous norepinephrine sensitivity, (Aldred, 2009) although investigators have proposed that ACE inhibitors act on baroreceptors and block the production of angiotensin II within the medulla vasomotor centre (Weir, 2006). In patients with CHF, the benefits of ACE inhibitors are related to increases in cardiac index and stroke volume, with resultant decreases in pulmonary-capillary wedge pressure mean arterial pressure and systemic vascular resistance; these changes in turn decrease both preload and afterload. Microvascular endothelial dysfunction associated with atherosclerosis improves with the administration of ACE inhibitors. Weir (2006) showed that in adults with coronary atherosclerosis, a 10-minute intra-arterial infusion of enalaprilat augmented bradykinin- and acetylcholine-, but not sodium nitroprusside-, vasodilator responses, as confirmed by decreases in femoral vascular resistance index values over baseline. This indicates that ACE inhibition selectively improves endothelium- dependent vasodilation. In the second phase of the study, intra-arterial administration of a nitric oxide synthesis inhibitor blocked both acetylcholine- and bradykinin-induced vasodilator responses, suggesting that ACE inhibitor augmentation may be mediated by increased nitric oxide activity. It is also suggested that ACE inhibition may reduce the elevated procoagulatant activity associated with acute MI (Weir, 2006).

Decreased aldosterone production usually causes an increase in plasma potassium concentrations of patients treated with ACE inhibitors. Millar et al. showed that significant natriuresis occurred within 24 hours of the first dose of enalapril (the oral ethylester of enalaprilat) or lisinopril, although this effect did not persist after 8 days of therapy (Selman, 2007). Renal blood flow is regulated by the interaction of angiotensin II-mediated vasoconstriction and prostaglandin-related vasodilation. ACE inhibitor therapy, increases kidney perfusion and decreases renal vascular resistance, as they induce vasodilation in both afferent and efferent arterioles. Although anecdotal data exists regarding use of ACE inhibitors in acute settings, their use is not recommended to stabilise acutely ill patients in the ICU or for those with pressor support requirement (Selman, 2007).

Although the incidence of symptomatic hypotension during administration of ACE inhibitors in healthy patients is low, in patients with left ventricular dysfunction, hypotension following a dose of enalapril was the most common (2%) adverse effect noted during the first 2-7 days (Selman, 2007). Other common adverse effects of enalapril include dizziness, headache, fatigue, cough, dyspepsia, hyperkalaemia, elevated blood urea nitrogen, creatinine and diarrhea. Potentially serious adverse effects include angioedema, hyperkalaemia, hepatotoxicity, pancreatitis agranulocytosis and renal failure in the presence of bilateral renal artery stenosis.

Conclusions

Defining the transition from supportive cardiological management of heart failure to end-of-life palliative care is both complex and daunting for heart failure professionals. However, delay in recognizing this transition has resulted in unmet patient and carer needs for far too long. We need to accept that the course of congestive heart failure is both progressive and unpredictable, despite optimal cardiological treatments. As patients progress to congestive heart failure, with refractory symptoms it is critical that heart failure professionals recognize the vital role they have in co-ordinating and engaging in a collaborative and seamless approach to care. Models of care similar to the one that is outlined in this paper have the potential to provide a framework to support heart failure professionals throughout the UK with the translation and integration of national palliative care recommendations into mainstream heart failure programmes.

Distinguish between ethical problems and other medical, social and legal problems.Muna was admitted via the Emergency Department to the ward following a fall at home. She was treated for a fractured neck of femur and had a total hip replacement from which she is recovering well.

Distinguish between ethical problems and other medical, social and legal problems.Muna was admitted via the Emergency Department to the ward following a fall at home. She was treated for a fractured neck of femur and had a total hip replacement from which she is recovering well.

Nursing Ethical and Legal Case Study

Case Study : The Case of Muna

Muna was admitted via the Emergency Department to the ward following a fall at home. She was treated for a fractured neck of femur and had a total hip replacement from which she is recovering well. She is 66 years old, recently widowed and, two years ago, she was diagnosed with Alzheimer’s disease.
Muna displays certain behaviours that are annoying other patients on the ward and some of the nursing staff. The main issue is that she refuses to remain either in bed or in her chair and attempts to mobilise without assistance. She continually appears agitated and can be aggressive to other patients who try to approach her. The nursing staff are concerned for her safety and the safety of other patients.
To address Muna’s behaviour, a nurse has contacted the doctor to discuss prescribing sedative medication and the doctor has consequently prescribed diazepam to see if it would help.
Muna’s family visit her in the afternoon and find her lying in a wet bed. She is non responsive and very sleepy. They are concerned that she no longer seems able to recognise them or respond to their questions.
They complain to the nursing staff that they were not consulted about their mother’s treatment and insist on the sedative being discontinued.
• Use the ethical decision making framework to determine your recommendations for the ongoing care of Muna
• Consider the legal and ethical implications surrounding the chemical restraint of Muna.
Can chemical restraint be justified to be in the best interests of Muna
Consider interests of all stakeholders and resource availability
Consider Safety and hazards
Consider mental health legislation.